Kliniska studier för Psoriasis i Washington
3 studier för Psoriasis söker deltagare vid platser i Washington.
Officiell studietext (engelska)
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
- Vanda Investigational Site, Spokane
RekryterarFas 3
Ålder 18 till 65 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07362017A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Bellevue Dermatology Clinic, Bellevue
- Dermatology of Seattle, Burien
RekryterarFas 4
Ålder 18 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT06857942A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Frontier Derm Partners, Mill Creek
- Local Institution - 0264, Spokane
RekryterarFas 3
Ålder 12 till 17 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06979453Från ClinicalTrials.gov, data hämtad 3 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.